BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33140823)

  • 21. Ultraviolet Radiation and Kaposi Sarcoma Incidence in a Nationwide US Cohort of HIV-Infected Men.
    Cahoon EK; Engels EA; Freedman DM; Norval M; Pfeiffer RM
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of Kaposi sarcoma among injection drug users with AIDS in the United States.
    Atkinson JO; Biggar RJ; Goedert JJ; Engels EA
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1282-7. PubMed ID: 15385736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project.
    Stiller CA; Trama A; Brewster DH; Verne J; Bouchardy C; Navarro C; Chirlaque MD; Marcos-Gragera R; Visser O; Serraino D; Weiderpass E; Dei Tos AP; Ascoli V;
    Cancer Epidemiol; 2014 Dec; 38(6):670-8. PubMed ID: 25454979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
    Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
    Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
    Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
    Chaturvedi AK; Mbulaiteye SM; Engels EA
    Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma.
    Séverin D; Bessaoud F; Meftah N; Du Thanh A; Tretarre B; Guillot B; Makinson A
    AIDS; 2021 Mar; 35(3):399-405. PubMed ID: 33181532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi sarcoma in Southern Finland (2006-2018).
    Kluger N; Blomqvist C; Kivelä P
    Int J Dermatol; 2019 Nov; 58(11):1258-1263. PubMed ID: 31222805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
    Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
    J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cohort profile: the South African HIV Cancer Match (SAM) Study, a national population-based cohort.
    Muchengeti M; Bartels L; Olago V; Dhokotera T; Chen WC; Spoerri A; Rohner E; Bütikofer L; Ruffieux Y; Singh E; Egger M; Bohlius J
    BMJ Open; 2022 Apr; 12(4):e053460. PubMed ID: 35410922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lifestyle factors associated with sex differences in Kaposi sarcoma incidence among adult black South Africans: A case-control study.
    Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
    Cancer Epidemiol; 2022 Jun; 78():102158. PubMed ID: 35421713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
    Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
    AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001-2015.
    Horner MJ; Shiels MS; Pfeiffer RM; Engels EA
    Clin Infect Dis; 2021 May; 72(9):e224-e231. PubMed ID: 32710777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
    Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
    Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
    Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81.
    Biggar RJ; Horm J; Fraumeni JF; Greene MH; Goedert JJ
    J Natl Cancer Inst; 1984 Jul; 73(1):89-94. PubMed ID: 6588239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of Kaposi sarcoma in the past 30 years in a tertiary hospital of the European Mediterranean basin.
    Marcoval J; Bonfill-Ortí M; Martínez-Molina L; Valentí-Medina F; Penín RM; Servitje O
    Clin Exp Dermatol; 2019 Jan; 44(1):32-39. PubMed ID: 29934954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.
    Liu L; Moke DJ; Tsai KY; Hwang A; Freyer DR; Hamilton AS; Zhang J; Cockburn M; Deapen D
    J Natl Cancer Inst; 2019 May; 111(5):509-518. PubMed ID: 30321398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.